Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in J Investig Allergol Clin Immunol

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    June 2022
  1. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Concomitant Efficacy of Dupilumab for severe atopic dermatitis and comorbid asthma in real-life conditions.
    J Investig Allergol Clin Immunol. 2022 Jun 20:0. doi: 10.18176/jiaci.0837.
    PubMed    


  2. OLAGUIBEL JM, Sastre J, Rodriguez JM, Del Pozo V, et al
    Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    J Investig Allergol Clin Immunol. 2022;32:165-180.
    PubMed     Abstract available


  3. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of the different healthcare professionals in the management of asthma patients. The GEMA-FORUM IV task force.
    J Investig Allergol Clin Immunol. 2022 Jun 8:0. doi: 10.18176/jiaci.0833.
    PubMed    


    May 2022
  4. GONZALEZ O, Picado C, Alobid I, Ramirez J, et al
    Eosinophilic sialodochitis: a rare comorbidity of severe asthma.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0817.
    PubMed    


  5. DOMINGUEZ-ORTEGA J, Luna-Porta JA, Olaguibel JM, Barranco E, et al
    Exacerbations among patients with asthma are largely dependent on the presence of multimorbidity.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0816.
    PubMed     Abstract available


    April 2022
  6. IZQUIERDO E, Rodriguez-Coira J, Delgado-Dolset MI, Gomez-Casado C, et al
    Epithelial Barrier: Protector and Trigger of Allergic Disorders.
    J Investig Allergol Clin Immunol. 2022;32:81-96.
    PubMed     Abstract available


  7. URIARTE SA, Gronlund H, Wintersand A, Bronge J, et al
    Clinical and Immunologic Changes due to Subcutaneous Immunotherapy With Cat and Dog Extracts Using an Ultrarush Up-Dosing Phase: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2022;32:133-140.
    PubMed     Abstract available


  8. BARROSO B, Valverde-Monge M, Alobid I, Olaguibel JM, et al
    Smell improvement by anti-IgE and anti-IL 5 biologics in patients with CRSwNP and severe asthma. A real life study.
    J Investig Allergol Clin Immunol. 2022 Apr 12:0. doi: 10.18176/jiaci.0812.
    PubMed     Abstract available


    March 2022
  9. SALOMONSSON M, Cardenas EI, Dahlin JS, Kalm-Stephens P, et al
    The proportion of FceRI+ blood monocytes increases with the degree of IgE sensitization in asthma.
    J Investig Allergol Clin Immunol. 2022 Mar 2:0. doi: 10.18176/jiaci.0797.
    PubMed    


    February 2022
  10. MIRALLES LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, et al
    Effectiveness of benralizumab in severe eosinophilic asthma under routine clinical practice.
    J Investig Allergol Clin Immunol. 2022 Feb 11:0. doi: 10.18176/jiaci.0793.
    PubMed    


    January 2022
  11. DELGADO ROMERO J, Blanco-Aparicio M, Cisneros Serrano C, Diaz-Perez D, et al
    Biological therapy at-home administration support for patients with severe asthma BioCart(c).
    J Investig Allergol Clin Immunol. 2022 Jan 24:0. doi: 10.18176/jiaci.0786.
    PubMed    


  12. VALVERDE-MOLINA J, Fernandez-Nieto M, Torres-Borrego J, Lozano Blasco J, et al
    Transition of adolescents with severe asthma from pediatric to adult care in Spain: the STAR consensus.
    J Investig Allergol Clin Immunol. 2022 Jan 12:0. doi: 10.18176/jiaci.0780.
    PubMed     Abstract available


    December 2021
  13. LEIRIA-PINTO P, Carreiro-Martins P, Peralta I, Marques J, et al
    Factors Associated With Asthma Control in 121 Preschool Children.
    J Investig Allergol Clin Immunol. 2021;31:471-480.
    PubMed     Abstract available


  14. DELGADO-ROMERO J, Pereyra-Rodriguez JJ
    Asthma mortality in Spain from 1980 to 2019. Trends and perspectives in new treatment era.
    J Investig Allergol Clin Immunol. 2021 Dec 13:0. doi: 10.18176/jiaci.0771.
    PubMed     Abstract available


    November 2021
  15. ANTONICELLI L, Tontini C, Garritani MS, Piga MA, et al
    Efficacy of mepolizumab in patients with concomitant severe eosinophilic asthma and severe chronic urticaria: an example of personalized medicine?
    J Investig Allergol Clin Immunol. 2021 Nov 29:0. doi: 10.18176/jiaci.0770.
    PubMed    


  16. VALERO A, Molina J, Nuevo J, Simon S, et al
    Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain.
    J Investig Allergol Clin Immunol. 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
    PubMed     Abstract available


  17. KALM-STEPHENS P, Nordvall L, Janson C, Malinovschi A, et al
    Sex differences in baseline risk factors for the incidence of asthma between early adolescence and young adulthood.
    J Investig Allergol Clin Immunol. 2021 Nov 18:0. doi: 10.18176/jiaci.0763.
    PubMed     Abstract available


  18. IZQUIERDO JL, Almonacid C, Campos C, Morena D, et al
    Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765.
    PubMed     Abstract available


    October 2021
  19. PACHOLCZAK-MADEJ R, Kuszmiersz P, Iwaniec T, Zareba L, et al
    Endothelial Dysfunction and Pentraxin-3 in Clinically Stable Adult Asthma Patients.
    J Investig Allergol Clin Immunol. 2021;31:417-425.
    PubMed     Abstract available


  20. VILLALOBOS-VIOLAN V, Betancor D, Mahillo-Fernandez I, Sastre J, et al
    Nonasthmatic Eosinophilic Bronchitis and Asthma Development: analysis of biomarkers.
    J Investig Allergol Clin Immunol. 2021 Oct 15:0. doi: 10.18176/jiaci.0738.
    PubMed    


  21. LEAL M, Paciencia I, Farraia M, Cavaleiro Rufo J, et al
    Airborne Food Allergen and Aeroallergen Levels in Health Care Settings: An Unaccounted for but Potentially Relevant Source of Exposure?
    J Investig Allergol Clin Immunol. 2021;31:426-432.
    PubMed     Abstract available


    September 2021
  22. DAVILA I, Campo P, Cimbollek S, Almonacid Sanchez C, et al
    Cluster sub-analysis of patients with severe asthma who responded to omalizumab.
    J Investig Allergol Clin Immunol. 2021 Sep 28:0. doi: 10.18176/jiaci.0731.
    PubMed    


  23. GIL-MARTINEZ M, Rodrigo-Munoz JM, Sastre B, Canas JA, et al
    Serum microRNAs catalog asthmatic patients by phenotype.
    J Investig Allergol Clin Immunol. 2021 Sep 6:0. doi: 10.18176/jiaci.0753.
    PubMed     Abstract available


  24. DELGADO ROMERO J, Nunez Palomo S, Urendez Ruiz AM, Gomez Ruiz F, et al
    Referral criteria for asthma and the pandemic: new challenges, new responses.
    J Investig Allergol Clin Immunol. 2021 Sep 3:0. doi: 10.18176/jiaci.0747.
    PubMed    


    July 2021
  25. ALMONACID SANCHEZ C, Melero Moreno C, Quirce Gancedo S, Sanchez-Herrero MG, et al
    PAGE Study: Summary of a Study Protocol to Estimate the Prevalence of Severe Asthma in Spain Using Big Data Methods.
    J Investig Allergol Clin Immunol. 2021;31:308-315.
    PubMed     Abstract available


    June 2021
  26. EXTREMERA ORTEGA AM, Moreno Lozano L, Gonzalez Jimenez OM, Borja Segade J, et al
    Findings in Chest High-Resolution Computed Tomography in Severe Asthma.
    J Investig Allergol Clin Immunol. 2021 Jun 29:0. doi: 10.18176/jiaci.0725.
    PubMed    


  27. PEREZ DE LLANO L, Blanco Cid N, Ortiz Piquer M, Dacal Rivas D, et al
    Compassionate Use of a Single Dose of Benralizumab in a Near-Fatal Asthma Exacerbation.
    J Investig Allergol Clin Immunol. 2021;31:268-270.
    PubMed    


  28. JACOME C, Pereira R, Almeida R, Amaral R, et al
    Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT).
    J Investig Allergol Clin Immunol. 2021;31:270-273.
    PubMed    


  29. BENZECRY V, Pravettoni V, Segatto G, Marzano AV, et al
    Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    J Investig Allergol Clin Immunol. 2021;31:261-263.
    PubMed    


    April 2021
  30. BARRANCO P, Palao P, Ruiz I, Dominguez-Ortega J, et al
    Relationship Between IgE-Mediated Sensitization to Staphylococcus aureus Enterotoxin B, Asthma Severity, and Atopy.
    J Investig Allergol Clin Immunol. 2021;31:170-173.
    PubMed    


  31. DELGADO ROMERO J, Miralles Lopez JC, Alvarez Puebla M, Fernandez Ibanez E, et al
    Severe Asthma Units Accredited by the Spanish Society of Allergology and Clinical Immunology (SEAIC): Experience and Future.
    J Investig Allergol Clin Immunol. 2021;31:182-184.
    PubMed    


  32. DELGADO J, Martinez-Moragon E, Fernandez-Sanchez T
    Factors Affecting the Success of Step-up Therapy in Patients With Moderate-Severe Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021;31:145-150.
    PubMed     Abstract available


  33. TEJEDOR-ALONSO MA, Farias-Aquino E, Perez-Fernandez E, Moro-Moro M, et al
    Association Between Severity of Anaphylaxis and Co-occurrence of Respiratory Diseases: A Systematic Review and Meta-analysis of Observational Studies.
    J Investig Allergol Clin Immunol. 2021;31:132-144.
    PubMed     Abstract available


  34. DIAZ-CAMPOS RM, Garcia-Moguel I, Pina-Maiquez I, Fernandez-Rodriguez C, et al
    Prevalence and influence of COVID19 in asthma control and lung function in severe asthma patients under biological treatment.
    J Investig Allergol Clin Immunol. 2021 Apr 15:0. doi: 10.18176/jiaci.0695.
    PubMed    


  35. BUENDIA JA, Acuna-Cordero R, Rodriguez-Martinez CE
    Budget impact analysis of Fractional Exhaled Nitric Oxide Monitoring for the Management of Childhood Asthma: The Colombian National Health System perspective.
    J Investig Allergol Clin Immunol. 2021 Apr 13:0. doi: 10.18176/jiaci.0690.
    PubMed     Abstract available


    March 2021
  36. PLAZA V, Trigueros JA, Cisneros C, Dominguez-Ortega J, et al
    The Importance of Small Airway Dysfunction in Asthma. The GEMA-FORUM III Task Force.
    J Investig Allergol Clin Immunol. 2021 Mar 12:0. doi: 10.18176/jiaci.0686.
    PubMed    


    February 2021
  37. DELGADO J, Davila IJ, Dominguez-Ortega J
    Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
    J Investig Allergol Clin Immunol. 2021;31:36-43.
    PubMed     Abstract available


  38. MIRALLES LOPEZ JC, Escudero Pastor AI, Carbonell Martinez A, Navarro Garrido C, et al
    Benralizumab in Real Life.
    J Investig Allergol Clin Immunol. 2021;31:87-88.
    PubMed    


  39. PLAZA V, Giner J, Curto E, Alonso-Ortiz MB, et al
    Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
    J Investig Allergol Clin Immunol. 2021;31:58-64.
    PubMed     Abstract available


    January 2021
  40. SATO H, Miyata Y, Inoue H, Tanaka A, et al
    Efficacy of Mepolizumab Extended Interval Dosing For Two Asthmatic Cases with Chronic Eosinophilic Pneumonia.
    J Investig Allergol Clin Immunol. 2021 Jan 26:0. doi: 10.18176/jiaci.0671.
    PubMed    


  41. BETANCOURT A, Zapatero A, Pola-Bibian B, Dominguez-Ortega J, et al
    Impact of Short-Term Exposure to Below Recommended PM10 Pollution Levels on Asthma Exacerbations.
    J Investig Allergol Clin Immunol. 2021 Jan 12:0. doi: 10.18176/jiaci.0663.
    PubMed    


    November 2020
  42. SERRANO P, Navas A, Ruiz-Leon B, Herrero L, et al
    Seasonal administration of omalizumab in patients with uncontrolled asthma and sensitization to olive pollen.
    J Investig Allergol Clin Immunol. 2020 Nov 25:0. doi: 10.18176/jiaci.0657.
    PubMed    


  43. KUROSAWA M, Shimizu Y, Sutoh Y, Sutoh E, et al
    Un-Sustained Response to Benralizumab in Eosinophilic Asthma with Previous 3 Year Mepolizumab Administration.
    J Investig Allergol Clin Immunol. 2020 Nov 2:0. doi: 10.18176/jiaci.0652.
    PubMed    


    October 2020
  44. CABALLERO ML, Dominguez J, Nin-Valencia AR, Sanchez-Ocando H, et al
    Eosinophil Count in Induced Sputum Could Be More Sensitive Than In Peripheral Blood to Phenotype Patients with Severe Eosinophilic Asthma.
    J Investig Allergol Clin Immunol. 2020 Oct 8:0. doi: 10.18176/jiaci.0647.
    PubMed    


    April 2020
  45. SHIMIZU Y, Kurosawa M, Sutoh Y, Sutoh E, et al
    Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.
    J Investig Allergol Clin Immunol. 2020;30:154-155.
    PubMed    


  46. OLAGUIBEL A, Oleaga M, Iraola A, Cortaberria R, et al
    Exhaled Nitric Oxide (eNO) Measurements With the New evernoa Device Are Valid and Reproducible Through an Extended Range of eNO Levels.
    J Investig Allergol Clin Immunol. 2020;30:147-149.
    PubMed    


    January 2020
  47. URIARTE SA, Sastre J
    Subcutaneous Immunotherapy With High-Dose Cat and Dog Extracts: A Real-life Study.
    J Investig Allergol Clin Immunol. 2020;30:169-174.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: